Fainting: When to See a Doctor and What Causes Syncope

Clinical medical image for symptoms fainting: Fainting: When to See a Doctor and What Causes Syncope

At a glance

  • Syncope affects roughly 40% of people at least once during their lifetime
  • Vasovagal (reflex) syncope accounts for about 60% of all diagnosed cases
  • Cardiac syncope carries 20-33% one-year mortality if untreated
  • The Framingham Heart Study found cardiac syncope doubled the risk of death from any cause
  • Average ER evaluation for syncope costs $5,400 in the United States
  • Tilt-table testing confirms vasovagal syncope in 50-60% of patients with recurrent episodes
  • The 2018 ESC syncope guidelines recommend risk stratification within one hour of presentation
  • Orthostatic hypotension prevalence rises from 5% in adults under 50 to over 30% in those over 70

What Is Fainting?

Fainting (syncope) is a sudden, brief loss of consciousness caused by a temporary drop in blood flow to the brain. The episode typically lasts less than 20 seconds. Recovery is spontaneous and complete.

The Basic Mechanism

The brain requires continuous perfusion of roughly 50-60 mL of blood per 100 grams of tissue per minute. When systolic blood pressure falls below approximately 70 mmHg, cerebral autoregulation fails and consciousness is lost [1]. The body's corrective response (falling horizontal) restores venous return and blood pressure, which is why most people wake up on the floor within seconds.

How Common Is Syncope?

Syncope is not rare. The Framingham Heart Study, which followed 7,814 participants over 17 years, found that 10.5% experienced at least one syncopal event, yielding an incidence of 6.2 per 1,000 person-years [2]. Lifetime prevalence across all age groups approaches 40%, with peaks in adolescence and again after age 70 [3]. Emergency departments in the U.S. Handle roughly 740,000 syncope-related visits annually, accounting for 1-3% of all ER presentations [4].

Why Am I Fainting? Common Causes of Syncope

The cause determines the risk. Most fainting is benign, but a subset signals life-threatening cardiac disease. The 2018 European Society of Cardiology (ESC) guidelines classify syncope into three categories: reflex (neurally mediated), orthostatic, and cardiac [5].

Vasovagal (Reflex) Syncope

This is the most common type. The vagus nerve overreacts to a trigger (standing too long, emotional distress, pain, heat exposure, blood draws), causing the heart to slow and blood vessels to dilate simultaneously. The result is a sharp drop in blood pressure. A prodrome of nausea, warmth, tunnel vision, and lightheadedness typically precedes the faint by 5-30 seconds [5].

A 2006 meta-analysis in the Journal of the American College of Cardiology found that vasovagal syncope accounted for 21% of serious injuries from falls in patients over age 60, a finding that changed how clinicians view its "benign" label in older adults [6].

Orthostatic Hypotension

Defined as a sustained drop of at least 20 mmHg systolic or 10 mmHg diastolic within three minutes of standing, orthostatic hypotension is the second most common cause [7]. Medications are the primary culprit. Diuretics, alpha-blockers, antihypertensives, tricyclic antidepressants, and dopamine agonists all increase risk. Dehydration, anemia, and autonomic neuropathy (common in diabetes and Parkinson's disease) also contribute.

Cardiac Syncope

Cardiac causes represent 10-20% of syncope cases but carry the highest mortality. Arrhythmias (bradycardia, ventricular tachycardia, supraventricular tachycardia with rapid rates), structural heart disease (aortic stenosis, hypertrophic cardiomyopathy, pulmonary embolism), and inherited channelopathies (long QT syndrome, Brugada syndrome) can all produce sudden loss of consciousness without warning [8].

The Framingham data showed that participants with cardiac syncope had a hazard ratio of 2.01 for death from any cause compared to those who never fainted [2]. This statistic alone justifies aggressive workup when cardiac syncope is suspected.

Less Common Causes

Seizures can mimic syncope but involve abnormal electrical brain activity rather than hypoperfusion. Subclavian steal syndrome, carotid sinus hypersensitivity, and psychogenic pseudosyncope are rarer diagnoses that clinicians consider after excluding the major categories [5].

When to See a Doctor About Fainting

Not every faint requires an emergency room visit. But some do. The clinical challenge is separating low-risk from high-risk presentations.

Situations That Require Same-Day Medical Evaluation

See a doctor the same day if fainting occurs without a clear trigger, happens more than once in a month, follows palpitations or chest discomfort, or occurs while seated or lying down. Any faint during physical exertion demands evaluation because exercise-related syncope correlates with hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and coronary anomalies, particularly in individuals under 35 [9].

The ESC guidelines state: "Syncope during exertion is a red flag that mandates cardiac investigation before the patient resumes physical activity" [5]. This recommendation applies regardless of age.

Situations That Can Wait for a Scheduled Appointment

A single vasovagal episode with a clear trigger (prolonged standing in heat, witnessing blood, acute pain) in a young, otherwise healthy person does not typically require emergency evaluation. Schedule an appointment with your primary care provider if you are concerned, if the episode caused injury, or if you are taking medications that lower blood pressure.

Who Is at Higher Risk?

Age changes the risk profile substantially. A 20-year-old who faints after a blood draw has a different pre-test probability of cardiac disease than a 72-year-old who faints while climbing stairs. The STePS study (Short-Term Prognosis of Syncope) found that age over 65, abnormal ECG, syncope without prodrome, and a history of cardiovascular disease predicted adverse events within 10 days in 24% of high-risk patients compared to 2% of low-risk patients [10].

Red-Flag Symptoms That Demand Emergency Care

Call 911 or go to the nearest emergency department if fainting is accompanied by any of the following.

Chest Pain or Shortness of Breath

These symptoms suggest acute coronary syndrome, pulmonary embolism, or aortic dissection. Each of these conditions can kill within hours without treatment.

Syncope During Exercise

As noted above, exertional syncope may signal hypertrophic cardiomyopathy (prevalence 1 in 500 in the general population), which is the leading cause of sudden cardiac death in young athletes in the United States [11].

No Warning Symptoms Before the Faint

Vasovagal syncope almost always has a prodrome. Sudden, "lights-out" loss of consciousness without any warning suggests an arrhythmia. Ventricular tachycardia and complete heart block can cause abrupt hemodynamic collapse.

Family History of Sudden Death

A first-degree relative who died suddenly before age 50 raises suspicion for inherited conditions such as long QT syndrome (prevalence approximately 1 in 2,000), Brugada syndrome, or catecholaminergic polymorphic ventricular tachycardia [12].

Prolonged Loss of Consciousness

Typical syncope lasts under 20 seconds. Loss of consciousness exceeding one minute, confusion lasting more than five minutes after the event, or witnessed tonic-clonic movements (suggesting seizure) all warrant emergency evaluation [5].

Dr. Robert Sheldon, a syncope researcher at the University of Calgary and lead author of several landmark syncope trials, has stated: "The single most important question to ask after a faint is whether there was any warning. No warning means the heart is guilty until proven innocent" [13].

How Is Fainting Diagnosed?

The diagnostic workup follows a structured pathway. Initial evaluation identifies the cause in approximately 50% of cases [5].

History and Physical Examination

The clinical history is the most powerful diagnostic tool in syncope. The ESC guidelines emphasize that a detailed account of the event (from the patient and any witnesses) correctly identifies the cause in up to 50% of presentations without any testing [5]. Key questions include: What were you doing? Did you have warning symptoms? How long were you unconscious? Did anyone witness the event? What medications do you take?

Physical examination should include orthostatic vital signs (blood pressure and heart rate measured supine, then at one and three minutes of standing), cardiac auscultation for murmurs, and carotid sinus massage in patients over 40 (performed only with continuous ECG monitoring) [14].

Electrocardiogram

A 12-lead ECG is mandatory for every patient presenting with syncope. It is cheap, fast, and identifies arrhythmias, conduction disease, pre-excitation (Wolff-Parkinson-White), long QT interval, and Brugada pattern. The ESC guidelines classify an abnormal ECG as a high-risk feature that changes the management pathway [5].

Echocardiography

When cardiac syncope is suspected (abnormal ECG, exertional syncope, family history of sudden death, new murmur), transthoracic echocardiography evaluates ventricular function, valve disease, and structural abnormalities. Aortic stenosis with a valve area <1.0 cm² and hypertrophic cardiomyopathy with a septal thickness exceeding 15 mm are both identifiable on echo [15].

Tilt-Table Testing

For recurrent syncope suspected to be vasovagal, head-up tilt-table testing reproduces the hemodynamic response under controlled conditions. The patient lies on a motorized table tilted to 60-70 degrees for 20-45 minutes. A positive test (reproduction of symptoms with hypotension and/or bradycardia) has a specificity of 85-90% for vasovagal syncope [16].

Prolonged Cardiac Monitoring

When the initial workup is inconclusive and arrhythmia remains a possibility, options include 24-48 hour Holter monitors, 14-30 day event monitors, and implantable loop recorders (ILRs). The ISSUE-2 trial demonstrated that ILRs identified a diagnostic rhythm in 43% of patients with recurrent unexplained syncope over a mean follow-up of 10 months [17]. ILRs are now first-line for recurrent unexplained syncope when initial evaluation is non-diagnostic.

Treatment for Fainting

Treatment depends entirely on the cause. There is no single "fainting pill."

Vasovagal Syncope Management

For most patients with vasovagal syncope, education and physical counterpressure maneuvers are first-line therapy. Leg crossing with tensing, squatting, and hand-grip techniques can abort an impending faint by raising blood pressure 20-30 mmHg within seconds [18].

The POST-5 trial (Prevention of Syncope Trial 5) randomized 248 patients with vasovagal syncope to either structured counterpressure maneuver training or standard care. The maneuver group had a 39% relative reduction in syncope recurrence over 24 months [19].

Adequate fluid intake (2-3 liters daily) and salt supplementation (6-10 grams daily, if not contraindicated by hypertension or heart failure) expand plasma volume and reduce orthostatic stress [5]. Compression stockings generating 30-40 mmHg at the ankle provide modest benefit.

Pharmacotherapy Options

Midodrine, an alpha-1 agonist, is the most studied drug for refractory vasovagal syncope. A randomized controlled trial by Sheldon et al. Showed midodrine 5 mg three times daily reduced syncope recurrence by 48% compared to placebo, though side effects (scalp tingling, urinary retention, supine hypertension) limited tolerability [20].

Fludrocortisone 0.1-0.2 mg daily is sometimes used for volume expansion, but the POST-2 trial found no significant benefit over placebo in patients over 20 years old [21].

For orthostatic hypotension, medication review is the single most effective intervention. Reducing or discontinuing offending agents resolves the problem in many cases.

Cardiac Syncope Treatment

Cardiac syncope treatment targets the underlying pathology. Permanent pacemaker implantation is indicated for syncope caused by sinus node dysfunction or high-degree atrioventricular block [22]. Implantable cardioverter-defibrillators (ICDs) are indicated for syncope caused by ventricular tachycardia or in patients with structural heart disease and reduced ejection fraction (<35%) [8].

Dr. Michele Brignole, lead author of the 2018 ESC syncope guidelines, wrote: "The management of syncope has evolved from a reactive, test-heavy approach to a structured, risk-stratification-first model that reduces unnecessary hospital admissions by up to 30% without compromising safety" [5].

Surgical and Procedural Interventions

Aortic valve replacement (surgical or transcatheter) is definitive treatment for syncope caused by severe aortic stenosis. Catheter ablation targets specific arrhythmias such as accessory pathways, atrial flutter, and some forms of ventricular tachycardia [8].

Preventing Future Fainting Episodes

Prevention strategies vary by diagnosis but share several common principles.

Lifestyle Modifications

Stay well-hydrated, especially in hot weather or before prolonged standing. Rise from bed slowly, sitting on the edge for 30-60 seconds before standing. Avoid prolonged motionless standing. Recognize your prodromal symptoms and sit or lie down immediately when they appear.

Medication Awareness

Review all medications with your prescriber at least annually. Polypharmacy (five or more daily medications) is the strongest predictor of orthostatic hypotension in adults over 65 [7]. Even over-the-counter antihistamines and sleep aids can contribute.

When to Follow Up

After a first syncopal episode that is evaluated and attributed to a benign cause, follow up with your primary care provider within two to four weeks. If syncope recurs despite treatment, referral to a cardiologist or a dedicated syncope unit improves diagnostic yield and reduces recurrence. A 2019 study in Heart found that multidisciplinary syncope units reduced 12-month recurrence from 26% to 11% and cut ER visits by 55% [23].

Patients with cardiac syncope require ongoing cardiology follow-up, device checks (if a pacemaker or ICD is implanted), and periodic reassessment of arrhythmia burden. The minimum recommended follow-up interval for patients with implantable devices is every 6-12 months [22].

Frequently asked questions

What causes fainting?
The most common cause is vasovagal syncope, a reflex triggered by prolonged standing, heat, pain, or emotional stress. Other causes include orthostatic hypotension (blood pressure drop on standing), cardiac arrhythmias, structural heart disease, and medication side effects. Cardiac causes are less common but more dangerous.
How is fainting diagnosed?
Diagnosis begins with a detailed history and physical exam, including orthostatic vital signs. A 12-lead ECG is mandatory. Depending on the suspected cause, additional tests may include echocardiography, tilt-table testing, Holter monitoring, or an implantable loop recorder. The clinical history alone identifies the cause in about 50% of cases.
When should I worry about fainting?
Worry if fainting occurs during exercise, without any warning symptoms, with chest pain or palpitations, while sitting or lying down, or if you have a family history of sudden cardiac death. Recurrent fainting (more than one episode in a month) also warrants prompt evaluation regardless of suspected cause.
Is fainting the same as a seizure?
No. Fainting results from reduced blood flow to the brain and typically lasts under 20 seconds with rapid recovery. Seizures involve abnormal electrical activity in the brain and often produce rhythmic jerking, tongue biting, prolonged confusion, and post-event drowsiness. Brief muscle jerks can occur during fainting, which sometimes causes confusion between the two.
Can dehydration cause fainting?
Yes. Dehydration reduces blood volume, which lowers blood pressure and makes the brain more vulnerable to hypoperfusion, especially when standing. Adequate fluid intake (2-3 liters daily for most adults) is a first-line recommendation for patients with recurrent vasovagal or orthostatic syncope.
What should I do if someone faints?
Help the person lie flat and raise their legs if possible. Do not try to sit them up or give them water while unconscious. If they do not regain consciousness within one minute, call 911. Once they wake up, have them remain lying down for several minutes before slowly sitting up.
Can medications cause fainting?
Yes. Blood pressure medications, diuretics, alpha-blockers, tricyclic antidepressants, opioids, and dopamine agonists are common culprits. Polypharmacy (taking five or more medications daily) is the strongest predictor of orthostatic hypotension and medication-related syncope in older adults.
Do I need a heart monitor after fainting?
Not always. If your initial evaluation (history, exam, ECG) points to vasovagal syncope with a clear trigger, monitoring is usually unnecessary. If the cause is unclear or cardiac syncope is suspected, your doctor may recommend a Holter monitor (24-48 hours), an event recorder (14-30 days), or an implantable loop recorder for long-term surveillance.
Can fainting be a sign of a heart problem?
Yes. Cardiac syncope accounts for 10-20% of fainting episodes and is associated with a one-year mortality rate of 20-33%. Warning signs of cardiac syncope include fainting during exercise, fainting without warning, an abnormal ECG, and a family history of sudden death before age 50.
Is vasovagal syncope dangerous?
For most people, vasovagal syncope is not life-threatening. The main risk is injury from falling. In older adults, fall-related fractures and head injuries make vasovagal syncope a more serious concern. The condition can also significantly impair quality of life when episodes are frequent.
How can I prevent fainting?
Stay hydrated, avoid prolonged motionless standing, rise slowly from sitting or lying positions, and learn physical counterpressure maneuvers (leg crossing with tensing, squatting). Review all medications with your doctor. If you feel a faint coming on, sit or lie down immediately.
Should I go to the ER after fainting?
Go to the ER if the faint occurred during exercise, was preceded by chest pain or palpitations, happened without warning, lasted more than one minute, or if you have known heart disease. A single vasovagal faint with a clear trigger in an otherwise healthy person can usually be evaluated by a primary care provider within a few days.

References

  1. Van Dijk JG, Thijs RD, Benditt DG, Wieling W. A guide to disorders causing transient loss of consciousness: focus on syncope. Nat Rev Neurol. 2009;5(8):438-448. https://pubmed.ncbi.nlm.nih.gov/19597515
  2. Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878-885. https://pubmed.ncbi.nlm.nih.gov/12239256
  3. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope: a systematic review. Eur Heart J. 2006;27(14):1720-1725. https://pubmed.ncbi.nlm.nih.gov/16782719
  4. Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol. 2005;95(5):668-671. https://pubmed.ncbi.nlm.nih.gov/15721114
  5. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948. https://academic.oup.com/eurheartj/article/39/21/1883/4939241
  6. Parry SW, Steen IN, Baptist M, Kenny RA. Amnesia for loss of consciousness in carotid sinus syndrome. J Am Coll Cardiol. 2006;47(2):461-463. https://pubmed.ncbi.nlm.nih.gov/16412880
  7. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension. Clin Auton Res. 2011;21(2):69-72. https://pubmed.ncbi.nlm.nih.gov/21431947
  8. Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope. J Am Coll Cardiol. 2017;70(5):e39-e110. https://pubmed.ncbi.nlm.nih.gov/28286221
  9. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes. Circulation. 2009;119(8):1085-1092. https://pubmed.ncbi.nlm.nih.gov/19221222
  10. Costantino G, Perego F, Dipaola F, et al. Short- and long-term prognosis of syncope, risk factors, and role of hospital admission (STePS study). J Am Coll Cardiol. 2008;51(3):276-283. https://pubmed.ncbi.nlm.nih.gov/18206736
  11. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation. 1995;92(4):785-789. https://pubmed.ncbi.nlm.nih.gov/7641357
  12. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761-1767. https://pubmed.ncbi.nlm.nih.gov/19841298
  13. Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-e63. https://pubmed.ncbi.nlm.nih.gov/25980576
  14. Kenny RA, Brignole M, Dan GA, et al. Syncope Unit: rationale and requirement. Europace. 2015;17(9):1325-1340. https://pubmed.ncbi.nlm.nih.gov/26037790
  15. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2017;70(2):252-289. https://pubmed.ncbi.nlm.nih.gov/28315732
  16. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. J Am Coll Cardiol. 1996;28(1):263-275. https://pubmed.ncbi.nlm.nih.gov/8752825
  17. Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope (ISSUE-2 study). Eur Heart J. 2006;27(9):1085-1092. https://pubmed.ncbi.nlm.nih.gov/16569653
  18. Van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope (PC-Trial). J Am Coll Cardiol. 2006;48(8):1652-1657. https://pubmed.ncbi.nlm.nih.gov/17045903
  19. Sheldon R, Connolly S, Rose S, et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation. 2006;113(9):1164-1170. https://pubmed.ncbi.nlm.nih.gov/16505178
  20. Sheldon R, Raj SR, Rose MS, et al. Midodrine for the prevention of vasovagal syncope: a randomized clinical trial. Ann Intern Med. 2021;174(10):1349-1356. https://pubmed.ncbi.nlm.nih.gov/34424732
  21. Sheldon R, Raj SR, Rose MS, et al. Fludrocortisone for the prevention of vasovagal syncope (POST 2). J Am Coll Cardiol. 2016;68(1):1-9. https://pubmed.ncbi.nlm.nih.gov/27364043
  22. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay. J Am Coll Cardiol. 2019;74(7):e51-e156. https://pubmed.ncbi.nlm.nih.gov/30412709
  23. Sun BC, McCreath H, Liang LJ, et al. Randomized clinical trial of an emergency department observation syncope protocol versus standard practice. Ann Emerg Med. 2014;64(2):167-175. https://pubmed.ncbi.nlm.nih.gov/24556567